Zydus Lifesciences Limited has informed the NSE about initiating a share buyback program. Detailed parameters regarding pricing, size, and timeline are expected in the official filing.
Board Meeting Grovy India Ltd's board meeting on 9/6/2026 to consider preferential issue of equity shares and recommend 1% final dividend of Rs. 0.10 per share for FY ended March 31, 2026,Neutral Grovy India Ltd's board meeting on 9/6/2026 to consider preferential issue of equity shares and recommend 1% final dividend of Rs. 0.10 per share for FY ended March 31, 2026,Neutral Grovy India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/06/2026 ,i
The Q4 FY26 earnings call transcript for Aarti Pharmalabs is now available via BSE filing. Investors can access the full discussion covering the company's quarterly performance and strategic outlook.
Zydus Lifesciences Limited (NSE: ZYDUSLIFE) has notified the exchanges about a share buyback program. The announcement signals the pharma major's intent to return capital to shareholders.
Zydus Lifesciences Limited has notified the exchange about a share buyback, marking another step in the pharmaceutical company's capital optimization efforts.
Omkar Pharmachem (OMKARPH) has released its audited financial results for the quarter and full year ending March 31, 2026, through official newspaper publications as per regulatory guidelines.
Aarti Pharmalabs has released the transcript of its Q4 FY26 earnings conference call on BSE, offering investors insights into management perspectives.
Amco India (AMCOIND) has published approved financial results for the fiscal year ended March 31, 2026 through official news advertisements.
Amco India (BSE: AMCOIND) has announced the approval of its financial results for the fiscal year ended March 31, 2026, with official news advertisements published.
ANS Industries (BSE: ANSINDUS) has announced the publication of its audited financial results for the quarter and year ended March 31, 2026, in compliance with SEBI regulations.
Omkar Pharmachem has published its audited financial results for Q4 and the fiscal year ended March 31, 2026, through official newspaper publications.
ANS Industries has released its audited financial results for the quarter and fiscal year ending March 31, 2026, through a regulatory filing with BSE under SEBI disclosure norms.
NSE & BSE filings, quarterly results, insider trades, and smart volume alerts — delivered on WhatsApp or Telegram. No separate app to install.
Need more? Pro tracks up to 500 companies with preferential issue alerts.
No credit card required. Connect WhatsApp or Telegram in minutes.